NIH-funded research Fellowship grant

Investigating how SETD2 affects brain function and its link to Fragile X Syndrome

Official title: Mechanisms of Setd2 in cortical circuit function: Convergence with Fragile X Syndrome

Funded at Ut Southwestern Medical Center · NIH-11025896 · Data updated 2026-11-12

This study is looking at how a gene called SETD2 affects brain function and behavior in conditions like autism and Fragile X Syndrome, using mice to learn more about how changes in this gene might help us understand these disorders better and improve care for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startJanuary 5, 2024
Project endNovember 4, 2026
Funding year2025
Award (this year)$40,506
NIH project number5F31NS132473-02
Project IDNIH-11025896 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with autism spectrum disorders or those with a family history of Fragile X Syndrome.

Less likely to help

Patients without autism spectrum disorders or related neurodevelopmental conditions may not receive direct benefits from this research.

What this research studies

This research explores the role of the SETD2 gene in regulating brain function, particularly in relation to autism spectrum disorders (ASD) and Fragile X Syndrome. By studying mice with a specific deletion of the Setd2 gene in their forebrain neurons, researchers aim to understand how changes in histone methylation affect neuronal circuits and behavior. The approach involves examining brain tissue to measure circuit excitability and gene expression, which could reveal important insights into neurodevelopmental disorders. Patients may benefit from a better understanding of the genetic factors contributing to their conditions.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the genetic mechanisms underlying autism and potentially inform future treatments.

How similar studies have gone: Previous research has shown promising results in understanding the role of histone modifications in neurodevelopmental disorders, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Pope, Alexander — Ut Southwestern Medical Center
  • Study coordinator: Pope, Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.